chr7-150974776-TGCGCGGCA-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.234_241delTGCCGCGC(p.Ala79fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,902 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
KCNH2
NM_000238.4 frameshift
NM_000238.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.70
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-150974776-TGCGCGGCA-T is Pathogenic according to our data. Variant chr7-150974776-TGCGCGGCA-T is described in ClinVar as [Pathogenic]. Clinvar id is 264104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-150974776-TGCGCGGCA-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.234_241delTGCCGCGC | p.Ala79fs | frameshift_variant | 2/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.234_241delTGCCGCGC | p.Ala79fs | frameshift_variant | 2/15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
KCNH2 | ENST00000532957.5 | n.457_464delTGCCGCGC | non_coding_transcript_exon_variant | 2/9 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1453902Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 722798
GnomAD4 exome
AF:
AC:
1
AN:
1453902
Hom.:
AF XY:
AC XY:
1
AN XY:
722798
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Petrovsky National Research Centre of Surgery, The Federal Agency for Scientific Organizations | Nov 28, 2022 | Heterozygous mutation c.234_241del (p.Ala79AspfsTer63) in KCNH2 gene was found in male proband (13 y.o., Caucasian) with Long QT syndrome. This variant is absent in Genome Aggregation Database (gnomAD) (date of access 2022-11-22). Functional analysis shows this mutation leads to a loss of hERG potassium channel function (PMID: 19668779). The variant has been reported in several articles (PMID: 36102233, 23098067, 19716085, 19668779). ClinVar contains entry on this variant (Variation ID: 264104). In accordance with ACMG(2015) criteria this variant is classified as Pathogenic with following criteria selected: PVS1, PS3, PS4_moderate, PM2. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 13, 2020 | PVS1, PS3, PS4_Moderate, PM2 - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2015 | The c.234_241delTGCCGCGC pathogenic mutation, located in coding exon 2 of the KCNH2 gene, results from a deletion of 8 nucleotides between positions 234 and 241, causing a translational frameshift with a predicted alternate stop codon. This mutation was detected in a proband with sports-induced syncope in childhood, atypical ECG findings, and family history which included seizures, dizziness, and abnormal ECG findings consistent with LQTS2 (Keller DI et al. Can J Cardiol 2009;25(8):455-62). In another study, this mutation was detected in two of 2500 individuals referred for LQTS-related genetic testing (Kapplinger JD et al. Heart Rhythm 2009;6(9):1297-303). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at